1. Home
  2. MMLP vs IPSC Comparison

MMLP vs IPSC Comparison

Compare MMLP & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMLP
  • IPSC
  • Stock Information
  • Founded
  • MMLP 2002
  • IPSC 2019
  • Country
  • MMLP United States
  • IPSC United States
  • Employees
  • MMLP N/A
  • IPSC N/A
  • Industry
  • MMLP Oil Refining/Marketing
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • MMLP Energy
  • IPSC Health Care
  • Exchange
  • MMLP Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • MMLP 155.2M
  • IPSC 146.2M
  • IPO Year
  • MMLP 2002
  • IPSC 2021
  • Fundamental
  • Price
  • MMLP $4.01
  • IPSC $1.14
  • Analyst Decision
  • MMLP
  • IPSC Strong Buy
  • Analyst Count
  • MMLP 0
  • IPSC 4
  • Target Price
  • MMLP N/A
  • IPSC $13.00
  • AVG Volume (30 Days)
  • MMLP 90.8K
  • IPSC 764.5K
  • Earning Date
  • MMLP 02-12-2025
  • IPSC 11-05-2024
  • Dividend Yield
  • MMLP 0.50%
  • IPSC N/A
  • EPS Growth
  • MMLP N/A
  • IPSC N/A
  • EPS
  • MMLP 0.11
  • IPSC N/A
  • Revenue
  • MMLP $717,396,000.00
  • IPSC $2,684,000.00
  • Revenue This Year
  • MMLP N/A
  • IPSC $230.56
  • Revenue Next Year
  • MMLP $0.80
  • IPSC $31.85
  • P/E Ratio
  • MMLP $37.37
  • IPSC N/A
  • Revenue Growth
  • MMLP N/A
  • IPSC 7.88
  • 52 Week Low
  • MMLP $2.04
  • IPSC $1.13
  • 52 Week High
  • MMLP $4.13
  • IPSC $5.51
  • Technical
  • Relative Strength Index (RSI)
  • MMLP 57.65
  • IPSC 36.11
  • Support Level
  • MMLP $3.98
  • IPSC $1.40
  • Resistance Level
  • MMLP $4.01
  • IPSC $1.74
  • Average True Range (ATR)
  • MMLP 0.02
  • IPSC 0.14
  • MACD
  • MMLP -0.00
  • IPSC -0.04
  • Stochastic Oscillator
  • MMLP 75.00
  • IPSC 1.43

About MMLP Martin Midstream Partners L.P. Limited Partnership

Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Share on Social Networks: